ArticleJournal of nanobiotechnology2024

Targeted degradation of oncogenic BCR-ABL by silencing the gene of NEDD8 E3 ligase RAPSYN.

Yanzi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.